In situ synthesis of graphene oxide/gold nanocomposites as ultrasensitive surface-enhanced Raman scattering substrates for clenbuterol detection
- 72 Downloads
A highly sensitive approach to detect trace amount of clenbuterol (CB) based on graphene oxide/gold nanoparticles (GO/Au NPs) by surface-enhanced Raman spectroscopy (SERS) was presented. To be specific, the GO/Au nanocomposites were formed by depositing Au NPs onto the surface of GO through an in situ reduction process, where a high density of inherent hot spots was created between Au NPs. By optimizing the depositing density of Au NPs, the strongest electromagnetic coupling effect originating from highly dense hot spots was obtained. The optimized GO/Au was demonstrated to enhance the Raman signals of CB by 4.8 times more than that of CB enhanced by Au NPs. Moreover, GO/Au nanocomposites exhibit good biocompatibility and accessible surface for high adsorption of target molecules through the pi-pi stacking with graphene oxide. Hence, the proposed GO/Au nanocomposites were utilized to capture aromatic molecules like CB and served as excellent sensitive SERS-active substrates for sensing of it, which exhibited an excellent linear performance in the range of 5 × 10−8 to 1 × 10−6 mol/L with a limit of detection (LOD) of 3.34 × 10−8 mol/L (S/N = 3). Due to high-density hot spots with easy operation, this proposed GO/Au nanocomposite–based SERS technique holds great potential in the application of food safety analysis and biomedical science.
KeywordsSurface-enhanced Raman scattering Clenbuterol Graphene oxide Nanocomposite Trace detection
This work was financially supported by the National Natural Science Foundation of China (NSFC) (nos. 61805143), Shanghai Pujiang Program 18PJ1408700, National Key R&D Program of China 2017YFC0110200, and Shanghai Sailing Program 19YF1435400.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 2.Fu X, Chu Y, Zhao K, Li J, Deng A. Ultrasensitive detection of the β-adrenergic agonist brombuterol by a SERS-based lateral flow immunochromatographic assay using flower-like gold-silver core-shell nanoparticles. Microchim Acta. 2017;184(6):1711–9. https://doi.org/10.1007/s00604-017-2178-3.CrossRefGoogle Scholar
- 4.Gonzalez-Antuna A, Rodriguez-Gonzalez P, Lavandera I, Centineo G, Gotor V, Garcia Alonso JI. Development of a routine method for the simultaneous confirmation and determination of clenbuterol in urine by minimal labeling isotope pattern deconvolution and GC-EI-MS. Anal Bioanal Chem. 2012;402(5):1879–88. https://doi.org/10.1007/s00216-011-5611-1.CrossRefPubMedGoogle Scholar
- 6.Berendsen BJA, Meijer T, Mol HGJ, van Ginkel L, Nielen MWF. A global inter-laboratory study to assess acquisition modes for multi-compound confirmatory analysis of veterinary drugs using liquid chromatography coupled to triple quadrupole, time of flight and orbitrap mass spectrometry. Anal Chim Acta. 2017;962:60–72. https://doi.org/10.1016/j.aca.2017.01.046.CrossRefPubMedGoogle Scholar
- 7.Degand G, Bernes-Duyckaerts A, Maghuin-Rogister G. Determination of clenbuterol in bovine tissues and urine by enzyme immunoassay. Jagricfood Chem. 1992;40(1):70–5.Google Scholar
- 26.Goncalves G, Marques PAAP, Granadeiro CM, Nogueira HIS, Singh MK, Grácio J. Surface modification of graphene nanosheets with gold nanoparticles: the role of oxygen moieties at graphene surface on gold nucleation and growth. Chem Mater. 2009;21(20):4796–802. https://doi.org/10.1021/cm901052s.CrossRefGoogle Scholar
- 29.Emery JD, Wang QH, Zarrouati M, Fenter P, Hersam MC, Bedzyk MJ. Structural analysis of PTCDA monolayers on epitaxial graphene with ultra-high vacuum scanning tunneling microscopy and high-resolution X-ray reflectivity. Surf Sci. 2011;605(17-18):1685–93. https://doi.org/10.1016/j.susc.2010.11.008.CrossRefGoogle Scholar